Antacids Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

The report on the global antacids market provides qualitative and quantitative analysis for the period from 2021-2030. The global antacids market was valued at USD 5.07 billion in 2022 and is expected to reach USD 7.38 billion in 2030, with a CAGR of more than 4.11% during the forecast period 2023-2030. The study on antacids market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

Antacids are over-the-counter medications that individuals can obtain without a prescription. They consist of a blend of different compounds, with calcium, magnesium, and aluminum salts serving as the active components. The primary mode of action for antacids involves neutralizing the stomach acid and inhibiting pepsin, an enzyme responsible for protein digestion. Each of these cationic salts possesses unique pharmacological properties that dictate their specific clinical applications. The increasing geriatric population around the world is the major driving factor responsible for the growth of the antacids market. According to data from World Population Prospects, the number of people aged 65 and older is projected to increase from 10% in 2022 to 16% in 2050. According to the 2019 World Population Prospects, by 2050, one in 6 people in the world will be over age 65. Additionally, the intake of medication for other medical conditions, which are associated with acid reflux and excess acid production also accounts for significant demand for antacids among this population.

Antacid tablets serve as widely used pharmaceutical products intended to alleviate symptoms associated with excessive stomach acidity and indigestion. These tablets are conveniently available without a prescription, making them easily attainable for consumers seeking prompt relief from common gastrointestinal discomfort. In addition, the primary purpose of antacid tablets is to counteract surplus stomach acid. They accomplish this by employing a blend of active ingredients, typically composed of various mineral salts like calcium, magnesium, and aluminum. These minerals function by interacting with the acidic substances present in the stomach, effectively neutralizing the acid and mitigating its potentially harmful effects on the stomach lining. Consequently, antacids are effective in relieving common symptoms such as heartburn, acid reflux, and stomach upset.

North America accounted for the largest share in the AI in the logistics market, in terms of region. The dominance of the U.S. in the field of AI is majorly attributed to the growth of AI in the logistics market in the North America region. High investment in AI by the government and private firms is supporting the market growth in North America. Moreover, North America region includes countries such as the U.S., and Canada has a large number of manufacturing facilities. Due to this, the demand for logistics is high in this region, as the manufacturing sector is a major end-user of logistics. The logistics suppliers use AI to match the growing demand from the manufacturing sector, in turn, augmenting the growth of Antacids in the North America region.

Report Findings

1) Drivers

• The rising prevalence of digestive disorders is driving the growth of the market.
• The changing dietary habits are contributing to the growth of the market.

2) Restraints

• The side effects associated with the consumption of antacids can hamper the growth of the market.

3) Opportunities

• Innovative product development may provide lucrative opportunities for the growth of the market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global antacids market is segmented on the basis of drug class, formulation, and distribution channel.

The Global Antacids Market by Drug Class

• Proton Pump Inhibitor
• H2 Antagonist
• Acid Neutralizers

The Global Antacids Market by Formulation

• Tablet
• Liquid
• Powder

The Global Antacids Market by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Company Profiles

The companies covered in the report include

• GSK plc.
• Bayer AG
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Procter & Gamble
• Acme United Corporation
• Allegiant Health
• Dr. Reddy’s Laboratories Ltd.
• Reckitt Benckiser Group PLC
• WellSpring Pharmaceutical Corporation

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the antacids market.
2. Complete coverage of all the segments in the antacids market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global antacids market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.